Citatuzumab bogatox

Citatuzumab bogatox (VB6-845) is recombinant immunotoxin that composed of Fab fragment of humanized antibody targeting EpCAM and a modified cytotoxin bouganin. Citatuzumab bogatox binds to and selectively induces apoptosis in EpCAM-positive cell lines and shows good activity in EpCAM-positive human tumour xenograft models.
Read more
€0.00 (tax incl.)
Reference:
HY-P99282
Product Details
HY-P99282

Data sheet

Size
Multiple sizes
Reactivity
Apoptosis
Application
Cancer-programmed cell death
CAS
945228-49-9

Menu

Settings